Leading UK charity urges preparation plan for new dementia treatments

14 September 2016
alzheimers-research-uk

Alzheimer’s Research UK, the Britain’s leading dementia research charity, is calling for an urgent plan for managing how new medicines are brought to patients, in a report that highlights several obstacles it fears could delay delivery of the next wave of dementia treatments.

The report, Treatments of Tomorrow: Preparing for breakthroughs in dementia, outlines a number of challenges and pressures in England’s healthcare system that may pose problems for the roll-out of disease-modifying treatments for dementia. The charity argues that as research continues to make progress, these challenges should be tackled now to pave the way for future scientific advances that could improve treatments and care.

The comprehensive report recommends a number of actions, including:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical